Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
This article examines the current evidence on GLP-1 medicines and cancer risk, regulatory guidance, and when patients should discuss concerns with their healthcare provider
J., Brannon, A
The keywords included trisomy 21, Down syndrome, oxidative stress, antioxidant capacity, lipid peroxidation, mitochondrial dysfunction, serine/threonine protein kinase, neurogenesis, antioxidant treatment, and clinical trials
This work was supported by NIH grant R01 HL 107904.
BestleDHeindlMRLimburgHVan Lam VanTPilgramOMoultonHet al
US$ 24.71
US$ 23.60
US$ 26.21
